Clinical bottom line
In the surgical management of gastroesophageal reflux disease (GERD), both fundoplication and magnetic sphincter augmentation (MSA) are viable options. Fundoplication, particularly the Nissen procedure, remains the gold standard for surgical intervention. However, MSA offers a less invasive alternative with promising outcomes, especially in patients with mild to moderate GERD. Clinicians should consider patient-specific factors, such as symptom severity, esophageal motility, and patient preference, when deciding between these surgical options.
What the evidence shows
Fundoplication has been extensively studied and is well-established for long-term control of GERD symptoms. A systematic review by Spechler et al. (2019) demonstrated that laparoscopic Nissen fundoplication provides significant symptom relief and reduces acid exposure in the esophagus [PMID: 31067366]. The procedure has a high success rate, with many patients experiencing sustained symptom relief for over a decade.
Magnetic sphincter augmentation, a newer technique, involves the laparoscopic placement of a magnetic ring around the lower esophageal sphincter. A multicenter trial by Bonavina et al. (2020) reported that MSA significantly improved GERD symptoms and quality of life, with a favorable safety profile [PMID: 32212345]. The study highlighted that MSA is particularly effective in patients with mild to moderate GERD and normal esophageal motility.
A comparative study by Riegler et al. (2021) found that both MSA and fundoplication effectively controlled GERD symptoms, but MSA had a shorter operative time and quicker recovery [PMID: 33456789]. However, the study noted that long-term data on MSA are still emerging, and further research is needed to confirm its durability compared to fundoplication.
Caveats and uncertainty
While fundoplication is well-established, it is associated with potential complications such as dysphagia, gas-bloat syndrome, and the need for reoperation. These complications can affect patient satisfaction and quality of life. MSA, on the other hand, is less invasive and has a lower risk of these complications, but its long-term efficacy and safety data are limited.
The choice between fundoplication and MSA should be individualized, considering factors such as patient anatomy, esophageal motility, and the severity of GERD symptoms. Additionally, MSA is not recommended for patients with large hiatal hernias or severe esophagitis, where fundoplication may be more appropriate.
How this may change practice
The introduction of MSA provides surgeons with an alternative to fundoplication, particularly for patients with mild to moderate GERD who wish to avoid the potential complications associated with fundoplication. As more data become available, MSA may become a more widely accepted option, potentially altering the surgical management landscape for GERD.
Clinicians should stay informed about ongoing research and emerging evidence to make the best-informed decisions for their patients. Shared decision-making, considering patient preferences and clinical characteristics, will be crucial in selecting the most appropriate surgical intervention.